Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Cyclacel Pharmaceuticals, Inc. | t1700098_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Cyclacel Pharmaceuticals, Inc. | t1700098_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Cyclacel Pharmaceuticals, Inc. | t1700098_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Cyclacel Pharmaceuticals, Inc. | t1700098_ex31-1.htm |
| EX-23.1 - EXHIBIT 23.1 - Cyclacel Pharmaceuticals, Inc. | t1700098_ex23-1.htm |
| EX-10.14 - EXHIBIT 10.14 - Cyclacel Pharmaceuticals, Inc. | t1700098_ex10-14.htm |
| 10-K - FORM 10-K - Cyclacel Pharmaceuticals, Inc. | t1700098-10k.htm |
Exhibit 10.15
CYCLACEL PHARMACEUTICALS, INC.
200 Connell Drive, Suite 1500
Berkeley Heights, NJ 07922
December 22, 2016
Mr. Paul McBarron
c/o Cyclacel Pharmaceuticals, Inc.
200 Connell Drive, Suite 1500
Berkeley Heights, NJ 07922
Dear Mr. McBarron:
Reference is made to the agreement between us (the “Agreement”) made as of January 2, 2014. This will confirm our agreement to extend the Agreement through the period ended June 30, 2017. Please confirm your agreement to the foregoing by signing below in the space provided.
| Sincerely, | ||
| CYCLACEL PHARMACEUTICALS, INC. | ||
| By: | /s/ Spiro Rombotis | |
| Name: | Spiro Rombotis | |
| Title: | President & CEO | |
| ACKNOWLEDGED AND AGREED: | |
| /s/ Paul McBarron | |
| Paul McBarron |